Cefuroxime, Doxycycline, and Metronidazole Combination Therapy

Evidence for Combined Use

• Cefuroxime plus metronidazole is a well-validated combination used extensively in surgical prophylaxis, particularly for colorectal surgery, gynecological procedures, and intra-abdominal infections 1, 2, 3
• The American College of Surgeons recommends cefuroxime 1.5g IV plus metronidazole for multiple surgical procedures including gynecological surgery, colorectal surgery, and orthopedic procedures 2, 3

Pharmacological Compatibility

• No significant drug-drug interactions exist between cefuroxime, doxycycline, and metronidazole, providing synergistic coverage rather than antagonistic effects 5, 4, 6
• Each agent has a different mechanism of action and targets different bacterial populations, making combination therapy rational 6, 4

Practical Dosing Considerations

• Cefuroxime is typically dosed at 1.5g IV every 8 hours (or 750mg-1.5g depending on indication) 2, 3
• Doxycycline is typically dosed at 100mg orally twice daily 7, 4
• Metronidazole is typically dosed at 500mg orally or IV three times daily (or 1g for surgical prophylaxis) 2, 3

Clinical Context Matters

• The Infectious Diseases Society of America recommends this combination for mixed aerobic-anaerobic infections requiring broad-spectrum coverage 6, 4
• This combination is particularly appropriate for pelvic inflammatory disease when both typical and atypical pathogens are suspected, intra-abdominal infections of moderate severity, and surgical prophylaxis for contaminated or clean-contaminated procedures 6, 2, 3